Skip to main content

Advertisement

SpringerLink
Log in

Update on invasive opportunistic mycoses: Clinical trials review, 2008–2009

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Invasive fungal infections remain major causes for morbidity and mortality in severely ill or immunocompromised patients. The past decade saw major expansion in the antifungal armamentarium, and the precise role of newer antifungal agents continues to be defined through clinical trials. This article summarizes five of the most relevant clinical trials related to prevention and treatment of opportunistic fungal infections in adult patients published between 2008 and 2009.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Betts RF, Nucci M, Talwar D, et al.; Caspofungin High-Dose Study Group: A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. Clin Infect Dis 2009, 48:1676–1684.

    Article  CAS  PubMed  Google Scholar 

  2. Groll AH, Mickiene D, Petraitiene R, et al.: Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling. Antimicrob Agents Chemother 2001, 45:2845–2855.

    Article  CAS  PubMed  Google Scholar 

  3. Maertens J, Raad I, Petrikkos G, et al.; Caspofungin Salvage Aspergillosis Study Group: Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004, 39:1563–1571.

    Article  CAS  PubMed  Google Scholar 

  4. Herbrecht R, Maertens J, Baila L, et al.: Caspofungin as first-line therapy of invasive aspergillosis in allogeneic hematopoietic stem cell transplant recipients: a study of the EORTC Infectious Diseases Group [abstract M2167]. Presented at the American Society for Microbiology 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC; October 25–27, 2008.

  5. Labelle AJ, Micek ST, Roubinian N, Kollef MH: Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med 2008, 36:2967–2972.

    Article  PubMed  Google Scholar 

  6. Schuster MG, Edwards JE Jr, Sobel JD, et al.: Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 2008, 149:83–90.

    PubMed  Google Scholar 

  7. Cornely OA, Maertens J, Winston DJ, et al.: Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007, 356:348–359.

    Article  CAS  PubMed  Google Scholar 

  8. Ullmann AJ, Lipton JH, Vesole DH, et al.: Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007, 356:335–347.

    Article  CAS  PubMed  Google Scholar 

  9. Rijnders BJ, Cornelissen JJ, Slobbe L, et al.: Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis 2008, 46:1401–1408.

    Article  CAS  PubMed  Google Scholar 

  10. Pascual A, Calandra T, Bolay S, et al.: Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008, 46:201–211.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, Children’s University Hospital, Albert-Schweitzer-Strasse 33, 48129, Münster, Germany

    Andreas H. Groll

Authors
  1. Andreas H. Groll
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas H. Groll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Groll, A.H. Update on invasive opportunistic mycoses: Clinical trials review, 2008–2009. Curr Infect Dis Rep 11, 417–419 (2009). https://doi.org/10.1007/s11908-009-0060-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-009-0060-0

Keywords

Search

Navigation